Personal Injury Cases

Personal injury cases vary as widely as the personal injuries themselves. When dealing with personal injury cases it is important to know the statute of limitations for bringing your case to trial.

The statute of limitations for personal injury cases varies by state for as little as 1-year to as much as 6-years depending upon the state. On this page are some high-profile personal injury cases, or case studies, if you will.

Some of the cases reported:

* A man who was traveling about 45 mph while cornering around a ramp had both front and rear tires on the left side ripped off from the rim. The truck rolled 8 times and flipped 1 1/2 times in the air. The man sustained several back injuries.
* A Ford Explorer fitted with Bridgestone tires had the left rear tire blow out causing it to roll several times. The man and woman driving were kill instantly. The left rear tire was shredded with the center missing. The tires were new and car had been serviced by authorized garage only a few days back.
* A driver in a Ford Explorer had a tire blow out and crossed the divider and hit one car, that was then struck by another car from behind. All three vehicles burned and were totaled. All involved in the accidents suffered major injuries including coma, facial scaring and injury to neck, back, arms, hands and legs.

More Cases - Drug Recalls

* Zyprexa (Olanzapine), which is prescribed for the treatment of schizophrenia and bipolar mania, has been linked to diabetes mellitus, hyperglycemia, pancreatitis and blood sugar disorders.
* Vioxx (Rofecoxib) is a Cox-2 inhibitor that was approved by the US Food and Drug Administration in 1999 for the treatment of arthritis, osteoarthritis, menstrual pain and for the management of acute pain in adults. Serious side effects have been noted such as kidney and cardiovascular failure and the increased risk of heart attack and stroke.
* Bextra has been a painkiller particularily popular with arthritis sufferers. However, the Cox-2 inhibitor allegedly increases the risk of stroke and heart attack in users.
* The Food and Drug Administration (FDA) directed manufacturers of all antidepressant drugs to revise the labeling for their products to include a boxed warning and expanded warning statements that alert health care providers to an increased risk of suicide (suicidal thinking and behavior) in children and adolescents being.
* On 12/17/04 Pfizer revealed that one of two clinical trials showed an increased cardiovascular risk for patients taking the arthrtitis medication Celebrex. Pfizer is taking steps to discover why there is a discrepancy between the two trials, but is not removing Celebrex from the marketplace.